This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,651,274 Albendazole 200 mg tablets. The $2,043.18 firm fixed price contract has a completion date of December 10, 2024 and was awarded on December 9, 2024. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Through this contract, Amerisourcebergen will supply critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to the DLA and its supported military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/16/25, 12:49 AM